United States Marshals Service

Ongoing Work

Attestation Reviews of DOJ's Fiscal Year 2017 Annual Accounting and Authentication of Drug Control Funds and Related Performance

The OIG is conducting attestation reviews of the Fiscal Year 2017 Annual Accounting of Drug Control Funds and Related Performance of DOJ's Assets Forfeiture Fund, Criminal Division, Drug Enforcement Administration, Federal Bureau of Prisons, Office of Justice Programs, Offices of the United States Attorneys, Organized Crime Drug Enforcement Task Forces, and United States Marshals Service, hereinafter referred to as "the components". Pursuant to 21 U.S.C. § 1703(d)(7), the Office of National Drug Control Policy (ONDCP) issued ONDCP Circular, Accounting of Drug Control Funding and Performance Summary, dated January 18, 2013, which requires the OIG to perform annual reviews of the components' drug control funds and related performance.

Audit of the Court Security Procurement Process

The OIG initiated an audit of the United States Marshals Service (USMS) court security officer services procurement. The objective is to assess the USMS's management of and processes for procuring court security officer services contracts.

Review of Gender Equity in the Department of Justice Law Enforcement Components

The OIG is examining gender equity in DOJ’s law enforcement components, specifically ATF, DEA, FBI, and USMS. The review will include an examination of component demographics and staff data related to promotions, awards, and gender discrimination complaints. The OIG will also assess staff perceptions related to gender equity and analyze the reasons for those perceptions.

Review of the Federal Bureau of Prisons' and U.S. Marshals Service's Pharmaceutical Drug Costs for Inmates and Detainees

The Office of the Inspector General (OIG) is initiating a review of the Federal Bureau of Prisons' (BOP) and U.S. Marshals Service's (USMS) pharmaceutical drug costs for inmates and detainees. This review will examine the budgetary impact of pharmaceutical drugs on the BOP and USMS, as well as their processes for obtaining pharmaceutical drugs.

USMS Hiring Practices

The OIG is investigating multiple allegations of improper or inappropriate hiring practices by officials at the United States Marshals Service (USMS), including allegations of nepotism, favoritism, and quid pro quo arrangements. The OIG is also examining the Department’s response to a letter from a Member of Congress to the Department regarding allegations of inappropriate hiring practices at USMS and whether officials at the USMS Office of General Counsel failed to ensure the Department’s response to the Member of Congress was accurate and complete.

Updated: November 2017